| Serial Number | 90536106 |
| Word Mark | CLATAZEV |
| Filing Date | Friday, February 19, 2021 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Monday, May 20, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 12, 2022 |
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 21, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Princeton, NJ 08543 |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Event Date | Event Description |
| Tuesday, February 23, 2021 | NEW APPLICATION ENTERED |
| Friday, May 21, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 14, 2021 | ASSIGNED TO EXAMINER |
| Wednesday, September 15, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 15, 2021 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 15, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, March 4, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 4, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 4, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 8, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, March 8, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, March 8, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, March 8, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, March 8, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 23, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 12, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 12, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 7, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, November 28, 2022 | SOU TEAS EXTENSION RECEIVED |
| Monday, November 28, 2022 | SOU EXTENSION 1 FILED |
| Monday, November 28, 2022 | SOU EXTENSION 1 GRANTED |
| Wednesday, November 30, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, May 30, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, May 30, 2023 | SOU EXTENSION 2 FILED |
| Tuesday, May 30, 2023 | SOU EXTENSION 2 GRANTED |
| Thursday, June 1, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, August 2, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, August 2, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, August 2, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, November 27, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, November 27, 2023 | SOU EXTENSION 3 FILED |
| Monday, November 27, 2023 | SOU EXTENSION 3 GRANTED |
| Wednesday, November 29, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, May 20, 2024 | SOU EXTENSION 4 FILED |
| Monday, May 20, 2024 | SOU EXTENSION 4 GRANTED |
| Monday, May 20, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, May 21, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, November 25, 2024 | SOU TEAS EXTENSION RECEIVED |